Logo image of UOKA

MDJM LTD (UOKA) Stock Fundamental Analysis

NASDAQ:UOKA - Nasdaq - KYG592901097 - Common Stock - Currency: USD

2.73  +0.48 (+21.33%)

Premarket: 2.65 -0.08 (-2.93%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to UOKA. UOKA was compared to 65 industry peers in the Real Estate Management & Development industry. While UOKA has a great health rating, there are worries on its profitability. UOKA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

UOKA had negative earnings in the past year.
In the past year UOKA has reported a negative cash flow from operations.
In multiple years UOKA reported negative net income over the last 5 years.
In the past 5 years UOKA always reported negative operating cash flow.
UOKA Yearly Net Income VS EBIT VS OCF VS FCFUOKA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M

1.2 Ratios

The Return On Assets of UOKA (-39.16%) is worse than 86.15% of its industry peers.
With a Return On Equity value of -41.88%, UOKA is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -39.16%
ROE -41.88%
ROIC N/A
ROA(3y)-31.34%
ROA(5y)-17.37%
ROE(3y)-35.29%
ROE(5y)-19.58%
ROIC(3y)N/A
ROIC(5y)N/A
UOKA Yearly ROA, ROE, ROICUOKA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for UOKA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
UOKA Yearly Profit, Operating, Gross MarginsUOKA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800

More info and screens

9

2. Health

2.1 Basic Checks

UOKA does not have a ROIC to compare to the WACC, probably because it is not profitable.
UOKA has about the same amout of shares outstanding than it did 1 year ago.
UOKA has more shares outstanding than it did 5 years ago.
UOKA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
UOKA Yearly Shares OutstandingUOKA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
UOKA Yearly Total Debt VS Total AssetsUOKA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

UOKA has an Altman-Z score of 153.29. This indicates that UOKA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 153.29, UOKA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for UOKA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 153.29
ROIC/WACCN/A
WACC9.2%
UOKA Yearly LT Debt VS Equity VS FCFUOKA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M 6M 8M

2.3 Liquidity

UOKA has a Current Ratio of 3.70. This indicates that UOKA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.70, UOKA belongs to the top of the industry, outperforming 81.54% of the companies in the same industry.
A Quick Ratio of 3.70 indicates that UOKA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.70, UOKA belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.7
Quick Ratio 3.7
UOKA Yearly Current Assets VS Current LiabilitesUOKA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.37% over the past year.
Looking at the last year, UOKA shows a very negative growth in Revenue. The Revenue has decreased by -76.58% in the last year.
UOKA shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -43.01% yearly.
EPS 1Y (TTM)43.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.12%
Revenue 1Y (TTM)-76.58%
Revenue growth 3Y-70.88%
Revenue growth 5Y-43.01%
Sales Q2Q%-75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UOKA Yearly Revenue VS EstimatesUOKA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

UOKA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UOKA Price Earnings VS Forward Price EarningsUOKA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UOKA Per share dataUOKA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

UOKA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MDJM LTD

NASDAQ:UOKA (5/20/2025, 8:00:01 PM)

Premarket: 2.65 -0.08 (-2.93%)

2.73

+0.48 (+21.33%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.99%
Inst Owner ChangeN/A
Ins Owners72.57%
Ins Owner ChangeN/A
Market Cap72.95M
AnalystsN/A
Price TargetN/A
Short Float %1.8%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 634.86
P/FCF N/A
P/OCF N/A
P/B 18.05
P/tB 18.05
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS0.15
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.16%
ROE -41.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-31.34%
ROA(5y)-17.37%
ROE(3y)-35.29%
ROE(5y)-19.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 99.34%
Cap/Sales 65.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.7
Quick Ratio 3.7
Altman-Z 153.29
F-Score3
WACC9.2%
ROIC/WACCN/A
Cap/Depr(3y)104.86%
Cap/Depr(5y)142.92%
Cap/Sales(3y)28.28%
Cap/Sales(5y)17.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-64.12%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-76.58%
Revenue growth 3Y-70.88%
Revenue growth 5Y-43.01%
Sales Q2Q%-75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.3%
OCF growth 3YN/A
OCF growth 5YN/A